Priority Review Sets Up Sanofi’s ‘Best In Disease’ Hemophilia Drug For 2023 Launch

Will Beat Gene Therapy To US Market

 
• By Andrew McConaghie
  
Sanofi logo
Sanofi looks to be on course to gain US approval by early 2023. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip